These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 17666524

  • 1. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia.
    Li J, Nanayakkara A, Jun J, Savransky V, Polotsky VY.
    Physiol Genomics; 2007 Oct 22; 31(2):273-80. PubMed ID: 17666524
    [Abstract] [Full Text] [Related]

  • 2. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha.
    Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, Semenza GL, Polotsky VY.
    Physiol Genomics; 2006 May 16; 25(3):450-7. PubMed ID: 16507783
    [Abstract] [Full Text] [Related]

  • 3. Intermittent hypoxia induces hyperlipidemia in lean mice.
    Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O'Donnell CP, Polotsky VY.
    Circ Res; 2005 Sep 30; 97(7):698-706. PubMed ID: 16123334
    [Abstract] [Full Text] [Related]

  • 4. Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N).
    Korn BS, Shimomura I, Bashmakov Y, Hammer RE, Horton JD, Goldstein JL, Brown MS.
    J Clin Invest; 1998 Dec 15; 102(12):2050-60. PubMed ID: 9854040
    [Abstract] [Full Text] [Related]

  • 5. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.
    Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL.
    Proc Natl Acad Sci U S A; 2003 Oct 14; 100(21):12027-32. PubMed ID: 14512514
    [Abstract] [Full Text] [Related]

  • 6. The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.
    Tarling EJ, Ahn H, de Aguiar Vallim TQ.
    Arterioscler Thromb Vasc Biol; 2015 Apr 14; 35(4):787-95. PubMed ID: 25593129
    [Abstract] [Full Text] [Related]

  • 7. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis.
    Drager LF, Jun J, Polotsky VY.
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr 14; 17(2):161-5. PubMed ID: 20125003
    [Abstract] [Full Text] [Related]

  • 8. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.
    Matsuda M, Korn BS, Hammer RE, Moon YA, Komuro R, Horton JD, Goldstein JL, Brown MS, Shimomura I.
    Genes Dev; 2001 May 15; 15(10):1206-16. PubMed ID: 11358865
    [Abstract] [Full Text] [Related]

  • 9. Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence.
    Barros D, García-Río F.
    Sleep; 2019 Mar 01; 42(3):. PubMed ID: 30476296
    [Abstract] [Full Text] [Related]

  • 10. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice.
    Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, O'Donnell CP, Polotsky VY.
    J Appl Physiol (1985); 2005 Nov 01; 99(5):1643-8. PubMed ID: 16037401
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis.
    Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL, Liang G.
    J Clin Invest; 2004 Apr 01; 113(8):1168-75. PubMed ID: 15085196
    [Abstract] [Full Text] [Related]

  • 12. The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients.
    Durst R, Jansen A, Erez G, Bravdo R, Butbul E, Ben Avi L, Shpitzen S, Lotan C, Leitersdorf E, Defesche J, Friedlander Y, Meiner V, Miserez AR.
    Atherosclerosis; 2006 Dec 01; 189(2):443-50. PubMed ID: 16466730
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
    Chen YX, Ruan XZ, Huang AL, Li Q, Moorhead JF, Varghese Z.
    Chin Med J (Engl); 2007 Dec 20; 120(24):2185-90. PubMed ID: 18167199
    [Abstract] [Full Text] [Related]

  • 14. Increased hepatic INSIG-SCAP-SREBP expression is associated with cholesterol metabolism disorder in assisted reproductive technology-conceived aged mice.
    Le F, Lou HY, Wang QJ, Wang N, Wang LY, Li LJ, Yang XY, Zhan QT, Lou YY, Jin F.
    Reprod Toxicol; 2019 Mar 20; 84():9-17. PubMed ID: 30562550
    [Abstract] [Full Text] [Related]

  • 15. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, Lv LL, Ruan XZ, Liu BC.
    Cardiovasc Res; 2013 Dec 01; 100(3):450-60. PubMed ID: 24068000
    [Abstract] [Full Text] [Related]

  • 16. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
    Wu Y, Ma KL, Zhang Y, Wen Y, Wang GH, Hu ZB, Liu L, Lu J, Chen PP, Ruan XZ, Liu BC.
    Liver Int; 2016 Oct 01; 36(10):1525-34. PubMed ID: 27028410
    [Abstract] [Full Text] [Related]

  • 17. siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys.
    Murphy BA, Tadin-Strapps M, Jensen K, Mogg R, Liaw A, Herath K, Bhat G, McLaren DG, Previs SF, Pinto S.
    Metabolism; 2017 Jun 01; 71():202-212. PubMed ID: 28521874
    [Abstract] [Full Text] [Related]

  • 18. Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice.
    Mastrocola R, Collino M, Rogazzo M, Medana C, Nigro D, Boccuzzi G, Aragno M.
    Am J Physiol Gastrointest Liver Physiol; 2013 Sep 15; 305(6):G398-407. PubMed ID: 23868406
    [Abstract] [Full Text] [Related]

  • 19. The cellular function of SCAP in metabolic signaling.
    Lee SH, Lee JH, Im SS.
    Exp Mol Med; 2020 May 15; 52(5):724-729. PubMed ID: 32385422
    [Abstract] [Full Text] [Related]

  • 20. Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
    Jensen KK, Tadin-Strapps M, Wang SP, Hubert J, Kan Y, Ma Y, McLaren DG, Previs SF, Herath KB, Mahsut A, Liaw A, Wang S, Stout SJ, Keohan C, Forrest G, Coelho D, Yendluri S, Williams S, Koser M, Bartz S, Akinsanya KO, Pinto S.
    J Lipid Res; 2016 Dec 15; 57(12):2150-2162. PubMed ID: 27707816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.